SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-17-009566
Filing Date
2017-10-20
Accepted
2017-10-19 20:27:18
Documents
3
Period of Report
2017-11-28
Effectiveness Date
2017-10-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT azrxdef14a_nov282017.htm DEF 14A 347446
2 IMAGE azurrx_logo.jpg GRAPHIC 7497
3 IMAGE spoor.jpg GRAPHIC 4081
  Complete submission text file 0001654954-17-009566.txt   364784
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 171145782
SIC: 2834 Pharmaceutical Preparations